Time/Aorta related events | Medical treatment, n, N (%) | Invasive treatment, n, N (%) | P value |
The acute phase (1 - 14 days) |
|
|
|
AD Periaortic hemorrhage Pleural effusion | 5.55 (9.1%) 5.55 (9.1%) 1.55 (1.8%) | 0.26 (0) 0.26 (0) 0.26 (0) | <0.001 <0.001 |
Death | 3.55 (1.8%) | 0.26 (0) |
|
The subacute phase (15 - 30 days), |
|
|
|
AD Periaortic hemorrhage Pleural effusion | 5.42 (11.9%) 2.42 (4.8%) 2.42 (4.8%) | 1.22 (2.6%) 0.22 (0) 0.22 (0) | <0.001 |
Death | 2.42 (4.8%) | 0.22 (0) |
|
The follow-up phase (2 - 12 months) |
|
|
|
AD Periaortic hemorrhage Pleural effusion | 1.32 (3.1%) 2.32 (6.3%) 1.32 (3.1%) | 0.17 (0) 0.17 (0) 0.17 (0) |
|
Death | 2.32 (6.3%) | 0.17 (0) |
|
The follow-up (13 - 24 months) |
|
|
|
AD Periaortic hemorrhage Pleural effusion | 1.27 (3.7%) 0.27 (0) 0.27 (0) | 0.12 (0) 0.12 (0) 0.12 (0) |
|
Death | 0.27 (0) | 0.12 (0) |
|
The follow-up (25 - 36 months) |
|
|
|
AD | 0.23 (0) | 0.6 (0) |
|
Periaortic hemorrhage Pleural effusion | 1.23 (4.3%) 0.23 (0) | 0.6 (0) 0.6(0) |
|
Death | 0.23 (0) | 0.6 (0) | . |
Overall events | 33.55 (60.0%) | 1.26 (3.8%) | <0.001 |
AD | 12.55 (30.9%) | 1.26 (0) | <0.001 |
Periaortic hemorrhage Pleural effusion Death | 10.55 (18.2%) 4.55 (7.3%) 7.55 (12.7%) | 0.26 (0) 0.26 (0) 0.26 (0) | <0.001 <0.001 <0.001 |